Clinical Trials Logo
  1. Home
  2. Chronic Prostatitis
  3. NCT05378646

Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis — ING-HP-1  

Chronic Prostatitis Clinical Trial

Official title:
An Open Controlled Study of the Efficacy and Safety of Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis

Clinical Trial Summary

The primary purposes of the study are to evaluate the effectiveness of Ingaron in the complex therapy of chronic prostatitis, to assess the safety of using Ingaron in patients with chronic prostatitis.

Clinical Trial Description

Literature data and the results of preclinical studies of interferon-gamma, as well as the features of the immunopathogenesis of chronic prostatitis, show the expediency of studying the use of Ingaron in this pathology. The study was conducted to compare the efficacy and safety of Ingaron in combination with standard therapy with its subcutaneous administration and standard therapy in patients with chronic prostatitis. The study was planned to include 50 male patients aged at least 18 years with a confirmed diagnosis of chronic prostatitis. In the course of the study, Ingaron was administered at a dose of 500,000 IU once a day, every other day. In addition to Ingaron, patients received antibiotic therapy, anti-inflammatory drugs, alpha-blockers (if necessary). Magnetic laser therapy and prostate massage were also provided. The patients were divided into 2 groups: main and control. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05378646
Study type Interventional
Source SPP Pharmaclon Ltd.
Contact
Status Completed
Phase Phase 3
Start date January 29, 2009
Completion date February 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT02898220 - Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Recruiting NCT05868668 - Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain N/A
Completed NCT02588274 - Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Withdrawn NCT03027076 - Microbiome of Urologic Chronic Pelvic Pain Syndrome N/A
Completed NCT00922012 - Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome N/A
Completed NCT00434343 - Physical Therapy Trial for Pelvic Pain N/A
Completed NCT05890235 - Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Phase 4
Recruiting NCT03641807 - Different Modes of Assessment on Acupuncture Effect on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Recruiting NCT04976751 - Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China Phase 1
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Completed NCT01843946 - Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Terminated NCT00301405 - Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain Phase 2
Not yet recruiting NCT06287970 - TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS N/A
Completed NCT01738464 - Microbiomes of Pelvic Pain
Completed NCT03543761 - Low-intensity Shockwave Therapy for Non-bacterial Prostatitis/Pelvic Pain Syndrome N/A
Completed NCT02711943 - Non Interventional Study of Levofloxacin in Chronic Prostatitis N/A
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Completed NCT02514265 - Trans-MAPP Symptom Patterns Study (SPS)
Recruiting NCT04128280 - Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis N/A
Recruiting NCT03629769 - Effects of Proxelan Somministration in Patients With Chronic Prostatitis Phase 3